Literature DB >> 7710906

Mechanisms of acquired resistance to cisplatin.

P A Andrews1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7710906     DOI： 10.1007/978-1-4615-2632-2_11

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  6 in total

1.  Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells.

Authors:  Ramakumar Tummala; Paula Diegelman; Sonia M Fiuza; Luis A E Batista de Carvalho; Maria Paula M Marques; Debora L Kramer; Kimberly Clark; Slavoljub Vujcic; Carl W Porter; Lakshmi Pendyala
Journal:  Oncol Rep       Date:  2010-07       Impact factor: 3.906

2.  Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts.

Authors:  Yonit Kasherman; Stefan Sturup; Dan Gibson
Journal:  J Biol Inorg Chem       Date:  2008-12-04       Impact factor: 3.358

3.  Caffeic acid phenethyl ester activates pro-apoptotic and epithelial-mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis.

Authors:  Claudia Gherman; Ovidiu Leonard Braicu; Oana Zanoaga; Anca Jurj; Valentina Pileczki; Mahafarin Maralani; Flaviu Drigla; Cornelia Braicu; Liviuta Budisan; Patriciu Achimas-Cadariu; Ioana Berindan-Neagoe
Journal:  Mol Cell Biochem       Date:  2016-02-02       Impact factor: 3.396

4.  Expression of Na,K-ATPase-beta(1) subunit increases uptake and sensitizes carcinoma cells to oxaliplatin.

Authors:  Ramakumar Tummala; Daniel Wolle; Sonali P Barwe; Valerie B Sampson; Ayyappan K Rajasekaran; Lakshmi Pendyala
Journal:  Cancer Chemother Pharmacol       Date:  2009-03-26       Impact factor: 3.333

5.  Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.

Authors:  Masumi Ishibashi; Masafumi Toyoshima; Xuewei Zhang; Junko Hasegawa-Minato; Shogo Shigeta; Toshinori Usui; Christopher J Kemp; Carla Grandori; Kazuyuki Kitatani; Nobuo Yaegashi
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

6.  Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells.

Authors:  Salma El-Shafie; Sherif Ashraf Fahmy; Laila Ziko; Nada Elzahed; Tamer Shoeib; Andreas Kakarougkas
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.